ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2023

Gene-Expression Analysis of Male and Female SLE Patients Reveals Candidate Pathogenic Pathways

MIKHAIL OLFERIEV1, David Fernandez 2, Dina Greenman 1, Mary Peng 1, Kyriakos Kirou 1 and Mary Crow 1, 1Hospital for Special Surgery, New York, NY, 2Hospital for Special Surgery, Mary Kirkland Center for Lupus Research, New York, NY

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: EGFR, estrogen and X-chromosome, sex bias, SLE

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: SLE – Etiology & Pathogenesis Poster II

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: The female predisposition for development of multiple autoimmune diseases is well recognized. The female to male ratio reaches a maximum during the reproductive years among SLE patients, suggesting a link between sexual development and disease. Additional epidemiologic data indicate an effect of sex chromosomes. To gain insight into molecular mechanisms of SLE, we investigated gene expression in PBMC of SLE patients and corresponding healthy donors of both genders using RNA-seq.

Methods: SLE samples were selected at a time of relative disease quiescence from a longitudinal cohort of patients. To minimize variation between male and female patients only demographically matched adults receiving low doses of steroids, hydroxychloroquine and mycophenolate motifil were selected and matched to healthy donors (HD). The analysis focused on identification of functional pathways affected in male and female SLE patients and abnormal gene expression from sex chromosomes.

Results: Principal component analysis differentiated the 4 donor groups, with PC1 and PC3 reflecting disease and PC2 reflecting gender. Male SLE patients received the highest score on PC1 and were placed closer to both SLE and healthy females than healthy males on PC2. We identified 796 and 99 differentially expressed genes in male and female SLE patients respectively, compared to HD (p< 0.05, logFC=1.5). Fewer genes (20 vs. 27) differed between genders in SLE vs. HD (p< 0.05, logFC=1.5). Weighted Gene Co-expression Network Analysis (WGCNA) identified 24 clusters of co-expressed genes in male and female patients. The most intriguing were clusters that differed in male and female HD and were upregulated in SLE of both genders. Those clusters include genes related to EGF receptor ligands (AREG, EREG, HBEGF), transcription factors (ATF3, NR4A1, NR4A2, NR4A3), cytokines and chemokines (CCL3, CXCL2, CXCL8, CCL3L3, IL1A, IL1B).  We also identified a group of X-chromosomal genes strongly upregulated in male SLE patients, including CXorf21.

Conclusion: Despite being clinically similar, male SLE patients showed a higher level of affected genes and had a lower divergence from females based on gender-related genes. Male HD had the lowest basal level of pro-inflammatory genes and EGF receptor ligands. The signaling through the EGF receptor has been shown to modulate the type I interferon response and may predispose females to autoimmune disease. The effect of X-chromosomal genes, including those that can escape inactivation in females, should be further investigated. We propose that gender-specific differences in gene expression reveal immunopathogenic mechanisms in autoimmune disease.


Disclosure: M. OLFERIEV, None; D. Fernandez, None; D. Greenman, None; M. Peng, None; K. Kirou, None; M. Crow, None.

To cite this abstract in AMA style:

OLFERIEV M, Fernandez D, Greenman D, Peng M, Kirou K, Crow M. Gene-Expression Analysis of Male and Female SLE Patients Reveals Candidate Pathogenic Pathways [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/gene-expression-analysis-of-male-and-female-sle-patients-reveals-candidate-pathogenic-pathways/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/gene-expression-analysis-of-male-and-female-sle-patients-reveals-candidate-pathogenic-pathways/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology